USFDA Inspection Systems in Pharma 2026 | 6 Systems + 483 Survival Guide USFDA Inspection Systems in Pharma: 6 Systems FDA Checks First + 2026 Survival Guide Updated: April 19, 2026 | Category: Regulatory Compliance | Reading Time: 10 min USFDA inspection is not an audit. Audit = you control timing. Inspection = FDA controls … Read more
FMEA Application in Pharma | ICH Q9 R1 Risk Management Guide + Template 2026 Application of FMEA Tool in Pharma Risk Management: Complete ICH Q9 R1 Guide 2026 Published: April 19, 2026 | Category: Quality Risk Management | Reading Time: 8 min Failure Mode and Effects Analysis = FMEA. It’s the first QRM tool USFDA … Read more
Risk Management in Pharma: ICH Q9 R1 Guide + 7 QRM Tools 2026 Quality Risk Management QRM is no longer optional in pharma. ICH Q9 R1 makes it mandatory across product lifecycle – from development to commercial manufacturing. But 80% of QA teams still do risk assessment as “copy-paste” exercise. Result: USFDA 483 for “Risk … Read more
ANDA Approval Process in USFDA: Complete Guide for Generic Drug Approval 2026 Want to launch a generic drug in USA? You need ANDA – Abbreviated New Drug Application approval from USFDA. Unlike NDA for innovators, ANDA proves your generic is same as Reference Listed Drug RLD in safety + efficacy. This guide covers ANDA vs … Read more
Vendor Management System (VMS) in Pharma: Complete GMP Compliance Guide 2026 In pharma, your product quality is only as good as your worst vendor. USFDA 483s and WHO audits fail companies not for their own mistakes, but for poor vendor control. A strong Vendor Management System VMS ensures every RM, PM, and service vendor meets … Read more
FDA 483 Form & FDA Inspection System: Complete Guide for Pharma Professionals If you work in pharma QA, “FDA 483” is the most feared 1-page form. It’s not a penalty. But if you ignore it, it becomes a Warning Letter, Import Alert, or plant ban. This guide explains what FDA Form 483 is, how FDA … Read more
Material Management in Pharma: The Backbone of GMP Compliance In pharma, “material” means everything that goes into or touches your product: APIs, excipients, packaging components, labels, even cleaning agents. If material management fails, batch fails. USFDA 483s and Schedule M non-compliances often start in the warehouse, not production. Material management in pharma is not just … Read more
Manufacturing Execution System in Pharma: From Paper BMR to Digital Factory Floor Walk into a modern pharma plant in 2026 and you’ll see fewer clipboards and more tablets. The reason: Manufacturing Execution System, or MES. MES is the software layer between ERP and machines on the shop floor. In pharma, it replaces paper Batch Manufacturing … Read more
Generic vs Brand-Name Drugs: Same Medicine, Different Price? Walk into any pharmacy and you’ll see two versions of the same drug on the shelf. One says “Paracetamol 500mg – Brand X” and costs ₹30. The other says “Paracetamol 500mg – Generic” and costs ₹3. Patients always ask the same question: “If the price is so … Read more
Upon meeting the requirements for the initiation of exhibit batches, the Quality Assurance (QA) department shall grant approval to proceed with the execution of the exhibit batch. The execution of exhibit batches will take place, and samples will be collected at various stages of manufacturing and packing, as outlined in the protocol. Any non-conformances identified … Read more
